Acute Coronary Syndromes
3 competing products in clinical development for Acute Coronary Syndromes.
Pipeline by Phase
Phase 11
Phase 32
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Triple oral lipid lowering treatment | Daiichi Sankyo | Phase 3 | Recruiting | 47 |
| Placebo + Prasugrel | Daiichi Sankyo | Phase 3 | Completed | 40 |
| clopidogrel + prasugrel | Daiichi Sankyo | Phase 1 | Terminated | 21 |